Resultados da pesquisa - brain ((tumor ras) OR (tumour rates)) treat

Pesquisas alternativas:
tumour rates » tumour sites (Expandir a Pesquisa), tumour rare (Expandir a Pesquisa), tumour late (Expandir a Pesquisa)
tumor ras » tumour ras (Expandir a Pesquisa), tumor tras (Expandir a Pesquisa), tumor rat (Expandir a Pesquisa)

21

Pazopanib reveals a role for tumor cell B-Raf in the prevention of HER2+ breast cancer brain metastasis

Pazopanib reveals a role for tumor cell B-Raf in the prevention of HER2+ breast cancer brain metastasis

Por Gril, Brunilde, Palmieri, Diane, Qian, Yong, Smart, DeeDee, Ileva, Lilia, Liewehr, David J., Steinberg, Seth M., Steeg, Patricia S.
Publicado em 2010

“... and treated with vehicle or pazopanib beginning on day 3 post-injection. Brain metastases were counted...”
Obter o texto integral
Obter o texto integral
Obter o texto integral

Artigo

22

CMET-19. CLINICAL RISK ASSESSMENT SCORE TO ESTIMATE THE LIKELIHOOD OF PSEUDOPROGRESSION VERSUS TUMOR GROWTH FOLLOWING STEREOTACTIC RADIOSURGERY FOR BRAIN METASTASES

CMET-19. CLINICAL RISK ASSESSMENT SCORE TO ESTIMATE THE LIKELIHOOD OF PSEUDOPROGRESSION VERSUS TUMOR GROWTH FOLLOWING STEREOTACTIC RADIOSURGERY FOR BRAIN METASTASES

Por Skeie, Bente, Øyvind Enger, Per, Pedersen, Paal-Henning, Olve Skeie, Geir
Publicado no Neuro Oncol (2018)

“...A major challenge in the follow-up of patients managed with stereotactic radiosurgery (SRS) brain...”
Obter o texto integral
Obter o texto integral

Artigo

23

Pattern of intracranial tumours in a tertiary hospital in Ghana

Pattern of intracranial tumours in a tertiary hospital in Ghana

Por Ekpene, Ubong, Ametefe, Mawuli, Akoto, Henry, Bankah, Patrick, Totimeh, Teddy, Wepeba, George, Dakurah, Thomas
Publicado no Ghana Med J (2018)

“... the clinical records of patients with intracranial tumours treated in our neurosurgery unit between January...”
Obter o texto integral
Obter o texto integral
Obter o texto integral

Artigo

24

Visual pathway glioma: an erratic tumour with therapeutic
dilemmas

Visual pathway glioma: an erratic tumour with therapeutic dilemmas

Por Shuper, A, Horev, G, Kornreich, L, Michowiz, S, Weitz, R, Zaizov, R, Cohen, I
Publicado em 1997

“...—VPG accounted for 13.1% of all brain tumours treated during this period. Sixty two per cent...”
Obter o texto integral
Obter o texto integral

Artigo

25

Whole brain radiotherapy for the treatment of newly diagnosed multiple brain metastases

Whole brain radiotherapy for the treatment of newly diagnosed multiple brain metastases

Por Tsao, May N, Lloyd, Nancy, Wong, Rebecca KS, Chow, Edward, Rakovitch, Eileen, Laperriere, Normand, Xu, Wei, Sahgal, Arjun
Publicado no Cochrane Database Syst Rev (2012)

“... 1.08, 95% CI 0.98 to 1.18, P = 0.11) or brain tumour response rates (HR 0.87, 95% CI 0.60 to 1.26, P...”
Obter o texto integral
Obter o texto integral
Obter o texto integral

Artigo

26

LGG-08. A PHASE II PROSPECTIVE STUDY OF SELUMETINIB IN CHILDREN WITH RECURRENT OR REFRACTORY LOW-GRADE GLIOMA (LGG): A PEDIATRIC BRAIN TUMOR CONSORTIUM (PBTC) STUDY

LGG-08. A PHASE II PROSPECTIVE STUDY OF SELUMETINIB IN CHILDREN WITH RECURRENT OR REFRACTORY LOW-GRADE GLIOMA (LGG): A PEDIATRIC BRAIN TUMOR CONSORTIUM (PBTC) STUDY

Por Fangusaro, Jason, Onar-Thomas, Arzu, Poussaint, Tina Y, Wu, Shengjie, Ligon, Azra H, Lindeman, Neal, Banerjee, Anu, Packer, Roger J, Kilburn, Lindsay B, Pollack, Ian F, Jakacki, Regina I, Qaddoumi, Ibrahim, Fisher, Paul G, Dhall, Girish, Baxter, Patricia, Kreissman, Susan G, Stewart, Clinton F, Pfister, Stefan M, Jones, David TW, Vezina, Gilbert, Stern, Jessica, Panigrahy, Ashok, Jones, Blaise V, Patay, Zoltan, Tamrazi, Benita, Jones, Jeremy Y, Haque, Sofia S, Enterline, David S, Cha, Soonmee, Doyle, Laurence A, Smith, Malcolm, Boyett, James M, Dunkel, Ira J, Fouladi, Maryam
Publicado no Neuro Oncol (2017)

“...A greater understanding of the Ras-MAP kinase-signaling pathway in pediatric low-grade glioma (LGG...”
Obter o texto integral
Obter o texto integral

Artigo

27

Is cell survival a determinant of the in situ response of 9L tumours?

Is cell survival a determinant of the in situ response of 9L tumours?

Por Wheeler, K. T., Wallen, C. A.
Publicado em 1980

“... using two sublines of the 9L rat brain tumour, designated 9L/Ro and 9L/SF. The median day of death...”
Obter o texto integral
Obter o texto integral

Artigo

28

The Profile of Tumor Antigens Which Can be Targeted by Immunotherapy Depends Upon the Tumor's Anatomical Site

Por Alonso-Camino, Vanesa, Rajani, Karishma, Kottke, Timothy, Rommelfanger-Konkol, Diana, Zaidi, Shane, Thompson, Jill, Pulido, Jose, Ilett, Elizabeth, Donnelly, Oliver, Selby, Peter, Pandha, Hardev, Melcher, Alan, Harrington, Kevin, Diaz, Rosa Maria, Vile, Richard
Publicado no Mol Ther (2014)

“... brain tumors. The optimal combination of antigens identified from the ASMEL which treated s.c. B16...”
Obter o texto integral
Obter o texto integral
Obter o texto integral

Artigo

29

Cell kinetics in leukaemia and solid tumours studied with in vivo bromodeoxyuridine and flow cytometry.

Cell kinetics in leukaemia and solid tumours studied with in vivo bromodeoxyuridine and flow cytometry.

Por Riccardi, A., Danova, M., Dionigi, P., Gaetani, P., Cebrelli, T., Butti, G., Mazzini, G., Wilson, G.
Publicado em 1989

“...), gastric cancer (42) and brain gliomas (20). The in vivo BUDR method requires that a single tumour sample...”
Obter o texto integral
Obter o texto integral

Artigo

30

Serial MRI Scan of Posterior Fossa Tumours Predict Patients at Risk of Developing Neurocognitive Impairment

Serial MRI Scan of Posterior Fossa Tumours Predict Patients at Risk of Developing Neurocognitive Impairment

Por Othman, Ramadhan T, Abdullah, Kurdistan Gh
Publicado no Asian Pac J Cancer Prev (2017)

“...BACKGROUND: Brain tumours are the most common solid tumours in children. More than 50...”
Obter o texto integral
Obter o texto integral
Obter o texto integral

Artigo

31

DIPG-11. ACTIVATION OF RAS SIGNALING AND DISTINCT MITOGEN-ACTIVATED PROTEIN KINASES (MAPKs) PROVIDES UNIQUE THERAPEUTIC VULNERABILITIES IN MUTANT HISTONE DIPG

DIPG-11. ACTIVATION OF RAS SIGNALING AND DISTINCT MITOGEN-ACTIVATED PROTEIN KINASES (MAPKs) PROVIDES UNIQUE THERAPEUTIC VULNERABILITIES IN MUTANT HISTONE DIPG

Por Koncar, Robert, Stanton, Ann-Catherine, Dey, Brittany, Agrawal, Nishant, Wassell, Michelle, McCarl, Lauren, Locke, Abigail, Sanders, Lauren, Vaske, Olena Morozova, Kohanbash, Gary, Felker, James, James, C David, Hashizume, Rintaro, Broniscer, Alberto, Pollack, Ian, Agnihotri, Sameer
Publicado no Neuro Oncol (2019)

“...Diffuse intrinsic pontine gliomas (DIPGs) are incurable pediatric brain tumors with an aggressive...”
Obter o texto integral
Obter o texto integral

Artigo

32

Whole brain radiotherapy versus stereotactic radiosurgery for 4–10 brain metastases: a phase III randomised multicentre trial

Whole brain radiotherapy versus stereotactic radiosurgery for 4–10 brain metastases: a phase III randomised multicentre trial

Por Zindler, Jaap D., Bruynzeel, Anna M. E., Eekers, Daniëlle B. P., Hurkmans, Coen W., Swinnen, Ans, Lambin, Philippe
Publicado no BMC Cancer (2017)

“... advantages of SRS over WBRT, i.e. limiting radiation doses to uninvolved brain and a high rate of local...”
Obter o texto integral
Obter o texto integral
Obter o texto integral

Artigo

33

Glioblastoma multiforme outcomes of 107 patients treated in two Singapore institutions

Glioblastoma multiforme outcomes of 107 patients treated in two Singapore institutions

Por Cheo, Song Tao Timothy, Lim, Gek Hsiang, Lim, Keith Hsiu Chin
Publicado no Singapore Med J (2017)

“...INTRODUCTION: Glioblastoma multiforme (GBM) is the most common primary brain tumour in adults...”
Obter o texto integral
Obter o texto integral
Obter o texto integral

Artigo

34

Cerebral FDG-PET scanning abnormalities in optimally treated HIV patients

Cerebral FDG-PET scanning abnormalities in optimally treated HIV patients

Por Andersen, Åse B, Law, Ian, Krabbe, Karen S, Bruunsgaard, Helle, Ostrowski, Sisse R, Ullum, Henrik, Højgaard, Liselotte, Lebech, Annemette, Gerstoft, Jan, Kjær, Andreas
Publicado em 2010

“... of circulating brain derived neurotrophic factor (BDNF) were performed to correlate these abnormalities...”
Obter o texto integral
Obter o texto integral
Obter o texto integral

Artigo

35

DIPG-22. GENETIC MODELING IMPLICATES RAS AND MYC AS KEY EPIGENETICALLY ACTIVATED TRANSCRIPTIONAL TARGETS OF H3K27M-DRIVEN CANCER

DIPG-22. GENETIC MODELING IMPLICATES RAS AND MYC AS KEY EPIGENETICALLY ACTIVATED TRANSCRIPTIONAL TARGETS OF H3K27M-DRIVEN CANCER

Por Siddaway, Robert, Pajovic, Sanja, Kim, Byungjin, Ryall, Scott, Agnihotri, Sameer, Li, Christopher, Hawkins, Cynthia
Publicado no Neuro Oncol (2019)

“... to primary high-grade gliomas. The tumors had a cell-type independent expression signature featuring RAS...”
Obter o texto integral
Obter o texto integral

Artigo

36

Pediatric low-grade glioma in the era of molecular diagnostics

Pediatric low-grade glioma in the era of molecular diagnostics

Por Scott Ryall, Uri Tabori, Cynthia Hawkins
Publicado em 2020-03-01

Assuntos: “...brain tumor...”
Obter o texto integral

Artigo

37

Integrative assessment of brain and bone invasion in meningioma patients

Integrative assessment of brain and bone invasion in meningioma patients

Por Zwirner, Kerstin, Paulsen, Frank, Schittenhelm, Jens, Gepfner-Tuma, Irina, Tabatabai, Ghazaleh, Behling, Felix, Skardelly, Marco, Bender, Benjamin, Zips, Daniel, Eckert, Franziska
Publicado no Radiat Oncol (2019)

“... modalities. In synopsis, brain or bone invasion did not show a significant influence on local control rates...”
Obter o texto integral
Obter o texto integral
Obter o texto integral

Artigo

38

P15.12 SURVIVAL AND QUALITY OF LIFE AFTER SURGERY FOR BENIGN INTRACRANIAL TUMOURS: AGE MATTERS?

P15.12 SURVIVAL AND QUALITY OF LIFE AFTER SURGERY FOR BENIGN INTRACRANIAL TUMOURS: AGE MATTERS?

Por Nocchi, N., Iacoangeli, M., Dobran, M., Di Rienzo, A., di Somma, L., Alvaro, L., Nasi, D., Benigni, R., Sessa, F., Scerrati, M.
Publicado em 2014

“...INTRODUCTION: Intracranial benign tumours are an increasingly common condition in the elderly...”
Obter o texto integral
Obter o texto integral

Artigo

39

$Hypofractionated high-energy proton-beam irradiation is an alternative treatment for WHO grade I meningiomas$

Hypofractionated high-energy proton-beam irradiation is an alternative treatment for WHO grade I meningiomas

Por Vlachogiannis, Pavlos, Gudjonsson, Olafur, Montelius, Anders, Grusell, Erik, Isacsson, Ulf, Nilsson, Kristina, Blomquist, Erik
Publicado no Acta Neurochir (Wien) (2017)

Assuntos: “...Clinical Article - Brain Tumors...”
Obter o texto integral
Obter o texto integral
Obter o texto integral

Artigo

40

Multidisciplinary management of clival chordomas; long-term clinical outcome in a single-institution consecutive series

Multidisciplinary management of clival chordomas; long-term clinical outcome in a single-institution consecutive series

Por Förander, Petter, Bartek, Jiri, Fagerlund, Michael, Benmaklouf, Hamza, Dodoo, Ernest, Shamikh, Alia, Stjärne, Pär, Mathiesen, Tiit
Publicado no Acta Neurochir (Wien) (2017)

Assuntos: “...Original Article - Brain Tumors...”
Obter o texto integral
Obter o texto integral
Obter o texto integral

Artigo

[1]
Anterior
1
2
3
4
5
6
7
Seguinte
[7]